Occupiers queueing up to be sent to Coventry

first_imgTo access this article REGISTER NOWWould you like print copies, app and digital replica access too? SUBSCRIBE for as little as £5 per week. Would you like to read more?Register for free to finish this article.Sign up now for the following benefits:Four FREE articles of your choice per monthBreaking news, comment and analysis from industry experts as it happensChoose from our portfolio of email newsletterslast_img

Brazil president signs law legalizing renegade cancer pill

first_imgResponding to political pressure and popular demand for a largely untested cancer drug, Brazilian President Dilma Rousseff signed into law today a measure that allows the renegade compound—synthetic phosphoethanolamine—to be produced and sold legally as a cancer therapy in Brazil.Scientists poured scorn on the decision, contending it puts patients at risk and undermines the authority of the Brazilian Health Surveillance Agency (the equivalent of the U.S. Food and Drug Administration) to regulate research and approval of new drugs based on internationally accepted safety and efficacy protocols. This was a “political decision inspired by a messianic surge of pseudoscience,” says Gustavo Fernandes, president of the Brazilian Society of Clinical Oncology in Brasília. “It was the worst possible way of dealing with this problem.”The “cancer pill” sparked a national debate last year after Brazilian media carried testimonials of patients claiming that it relieved symptoms or even cured their cancer. The compound was developed in the early 1990s by Gilberto Chierice, an analytical chemist at the University of São Paulo whose lab distributed it to patients free of charge for several years, without any regulatory approval or clinical oversight. Email Sign up for our daily newsletter Get more great content like this delivered right to you! Country Click to view the privacy policy. Required fields are indicated by an asterisk (*)center_img Country * Afghanistan Aland Islands Albania Algeria Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia, Plurinational State of Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, the Democratic Republic of the Cook Islands Costa Rica Cote d’Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See (Vatican City State) Honduras Hungary Iceland India Indonesia Iran, Islamic Republic of Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Korea, Democratic People’s Republic of Korea, Republic of Kuwait Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macedonia, the former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Martinique Mauritania Mauritius Mayotte Mexico Moldova, Republic of Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Norway Oman Pakistan Palestine Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Qatar Reunion Romania Russian Federation Rwanda Saint Barthélemy Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Martin (French part) Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten (Dutch part) Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania, United Republic of Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Venezuela, Bolivarian Republic of Vietnam Virgin Islands, British Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe Apart from a few studies in mouse models and in cell lines, there is no laboratory evidence that synthetic phosphoethanolamine works as a cancer drug. The university tried to shut down Chierice’s operation in June 2014, but since then more than 15,000 people sued the university, forcing it to continue providing them with the pills. Advocacy groups, meanwhile, pressured politicians and health authorities to legalize use of the compound as a cancer drug. Brazil’s congress passed a bill to do just that last month.Officials in the ministries of health, industry, and science advised Rousseff to veto the bill, according to O Estado de S. Paulo newspaper. But with Rousseff fighting for her political life—the congress is attempting to impeach her over allegations of fiscal improprieties—her executive office recommended signing the bill, sources say.The law authorizes production, prescription, and consumption of synthetic phosphoethanolamine as a cancer therapy “independently” of registration with the Brazilian Health Surveillance Agency. To acquire the pills, consumers must show medical proof that they have a malignant tumor and sign a consent form.Under the new law, the substance can only be produced and distributed by “licensed agents.” On 1 April, the University of São Paulo closed Chierice’s former research lab, which had until then been producing the pills under court orders. The only place the compound is currently being produced is a private lab contracted by the São Paulo state government to supply it for an upcoming clinical trial. The lab is preparing the pills according to a formula patented by Chierice and six colleagues; they claim their preparation is different from the synthetic phosphoethanolamine available on the international market as a dietary supplement.  Late last year, the science ministry committed to spending nearly $3 million on preclinical studies of synthetic phosphoethanolamine. Initial results, made public last month, were not promising. According to the experiments, conducted at four academic and private labs, the pills produced by Chierice’s group contained only 30% synthetic phosphoethanolamine, and the substance failed to kill cancer cells. It doesn’t appear to be toxic.At a 5 April hearing in Brazil’s Federal Senate, Chierice charged that the government-sponsored studies are being done in “bad faith,” and stated that his group is obtaining clinical data from overseas. The University of São Paulo in 2015 lodged a complaint with the police accusing Chierice of “curandeirismo,” or illegally dispensing unproven medical treatments. A criminal investigation is underway, according to news reports. “Maybe [Chierice] was well intentioned, but he did a lot of wrongs,” Fernandes says.The new law may please desperate cancer patients, but it’s an unfortunate move, says biochemist Luiz Fernando Lima Reis, research director at Hospital Sírio-Libanês in São Paulo, where high-profile politicians have been treated for cancer, including Rousseff in 2009 and former President Luiz Inácio Lula da Silva in 2011. “Decisions like this should be based on scientific evidence,” Reis says.last_img read more